5

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: February 8, 2019
Period of Report: December 31, 2018
Accession Number: 0001127602-19-004861

View Document ↗ View on SEC.gov ↗